Although snoring or sleep apnea might suggest a neck size associated with heart failure risk, the study did not conclude that ...

Published in the Nutrition Journal, the study found that looking at a person’s neck circumference could “improve the ...

Other studies conducted by Lilly show that the drug can also reduce the progression of heart failure and kidney disease.

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

Sleep apnea is a sleep disorder marked by interruptions ... risk of health complications like hypertension, diabetes, and heart disease. In addition to lifestyle changes and adjustments to ...

Trial data also showed that Zepbound lowered the so-called biomarkers of sleep apnea, including low blood oxygen and blood ...

Sleep apnea, a widespread health issue, causes breathing interruptions during sleep, leading to oxygen deprivation and various health problems. It manifests in obstructive, central, and mixed forms.

The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...